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Abstract
Introduction: This article presents how physical exercise can be considered as a 
complementary treatment in prostate cancer. The article presents the design and 
implementation of a strength-endurance physical exercise program adapted to prostate 
cancer. The initial model corresponds to the guidelines of the American College of Sports 
Medicine (ACSM, 1998). Adapting and transforming the program included the most 
common symptoms relating to the illness and its treatments.
Material and methods: The study design is quasi-experimental. The sample consisted of 
33 subjects in treatment phase. Study variables were anthropometric measures, strength-
endurance, hypertension, fatigue, incontinence, pain and quality of life.
Results: After 24 weeks of the program, a significant improvement in the strength-
endurance capacity was observed. This result was more evident in lower limbs. There 
were also improvements in hypertension, urinary incontinence and pain. In conclusion, 
the improvement in quality of life is due to the improvement of the functional and 
physical capacity of ill person.
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Introduction
The lack of physical activity and the sedentary lifestyles of 
the population are responsible for health, social and 
economic problems. The main aim of the National Institute 
of Health (NIH) and the American College of Sports Medicine 
(ACSM) is the promotion of physical exercise in all population 
groups for the improvement of health and prevention 
of illness. The long term objectives are to enhance 
performance in the undertaking of daily activities and to 
reduce the risk of pathologies associated with a sedentary 
lifestyle, such as coronary pathologies, obesity, type 2 
diabetes, hypertension, brain haemorrhage and cancer1. 
The recommendations are similar to those put forward by 
the American Heart Association and the Centres for Disease 
Control and Prevention (CDC)2. There are currently three 
general perspectives on the relationship between physical 
exercise and health: rehabilitative, preventative, and a 
perspective oriented to wellbeing. From the rehabilitative 
perspective, Airaska3 found that physical exercise can be 
considered as an instrument for the recovery of the 
debilitated or damaged corporal function and the alleviation 
of its effects on the human organism. Physical activity may 
be compared to medication and seen as a therapy that is 
complementary to medical pharmacological treatment for 
pathologies such as coronary disease, obesity, type 2 
diabetes, hypertension, brain haemorrhage and cancer.
This article focuses on the rehabilitative perspective of 
physical exercise in relation to prostate cancer for 
improvement of the quality of life (QoL) of subjects being 
treated for the illness.
The principal risk factor for prostate cancer is age (the 
average age for diagnosis is 75) followed by environmental 
influences and lifestyles4. The survival rate at 5-years is 
76.5% and there is a very high rate of morbidity caused by 
treatments. For these reasons, the priority objective for 
social-health intervention in cases of men suffering prostate 
cancer is improvement in QoL5.
QoL is a subjective, dynamic, multidimensional concept 
of modular paradigm and difficult measurement6. The QoL 
relative to cancer is a subjective experience of the illness 
that is contrasted with expectations, values and individual 
interests7 and corresponds with the dialectic that is 
established between subjective and objective aspects. The 
result of this relationship determines the appreciation or 
satisfaction of the functioning of the patient with that 
which is perceived as possible or ideal8.
The research corpus shows that the design and 
implementation of a strength-endurance exercise programme 
as a complementary treatment for the prostate cancer 
patient can reduce and even revert the physical and 
psychosocial degeneration and improve the QoL of the older 
male9-11. The majority of programmes are based on the 
general guidelines recommended by the American College 
Sports Medicine-Position stand that is aimed at the promotion 
of physical exercise in healthy individuals12. These programmes 
are not specifically adapted to the illness and its treatment; 
they are excessively generic, incomplete, inflexible and 
inefficient13.
The effectiveness of the programme is subject to the 
management and control of the variables that determine the 
characteristics of the activity. These variables must be 
adapted and transformed in accordance with the most 
common symptoms identified in the process and treatment 
of prostrate cancer and the comorbidity of the older male14. 
The consideration of these aspects facilitates the compatibility 
of the strength-endurance programme and its promotion for 
the alleviation of the degeneration and incapacity caused by 
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El ejercicio físico como terapia complementaria en el cáncer de próstata
Resumen
Introducción: Este artículo presenta el ejercicio físico como una terapia complementaria 
en el tratamiento del cáncer de próstata. En concreto presentamos el diseño e imple-
mentación de un programa de ejercicio físico de fuerza-resistencia adaptado al cáncer 
de próstata. El modelo base corresponde a la guía de la American College Sports Medici-
ne Position Stand (ACSM, 1998). La adaptación y la transformación del programa incluyen 
los síntomas más habituales relativos a la enfermedad y a sus tratamientos.
Material y métodos: El diseño del estudio es cuasiexperimental, con una muestra de 
33 participantes en fase de tratamiento. Las variables de estudio son las variables an-
tropométricas, fuerza-resistencia, tensión arterial, fatiga, incontinencia, dolor y calidad 
de vida.
Resultados: Al finalizar 24 semanas de programa, se observa una mejora significativa de 
la capacidad de la fuerza-resistencia, más evidente en las extremidades inferiores. Tam-
bién mejora la hipertensión arterial, la incontinencia urinaria y el dolor.
Conclusiones: Estos resultados demuestran que la mejora de la calidad de vida viene 
mediada por la mejora de la capacidad física y funcional del enfermo.
© 2009 Consell Català de l’Esport. Generalitat de Catalunya. Publicado por Elsevier 
España, S.L. Todos los derechos reservados.
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the disease and its treatment15. A programme based on these 
characteristics would result in greater effectiveness in the 
development of muscular strength-endurance and be 
reflected in the quality of the patient’s basic motor 
patterns16,17, delaying the onset of fatigue, reducing the 
processes of osteopenia and osteoporosis provoked by 
association with the factors of age, hormone treatment and 
inactivity. This, in turn, would reduce the risk of the fall-
fracture-dependence chain reaction often found in these 
debilitated patients18, thereby improving the QoL and survival 
possibilities of the older male suffering from prostate 
cancer19.
The objectives of this article are:
•  To present a programme of strength-endurance physical 
exercise, adapted to the needs of prostate cancer 
patients, in consideration of the significant variables 
detailed in studies with healthy or ill subjects with non-
carcinogenic pathologies.
•  To evaluate the physical and psychosocial results obtained 
after 24 weeks of the implementation of the programme.
Materials and methods
Locality and participants
After receiving approval from the Research Ethics Commit-
tee, the exercise programme was implemented at the Fi-
gueres Hospital (Girona, Spain), between October 2006 and 
October 2007.
Three conditions were required for patient inclusion:
•  A histological diagnosis of prostate cancer, at any stage of 
its pathology, in the process of treatment.
•  The undertaking of a medical examination in order to cer-
tify that the individual demonstrated no contraindications 
to the programme of exercise.
• The giving of informed consent by means of signature.
Exclusion criteria were the presence of any other 
pathology that contraindicated temporary or permanent 
participation in physical exercise activities, with absolute 
contraindications being groups III and IV of the New York 
Heart Association classification of cardiac disease, 
uncontrolled arterial hypertension, psychiatric illness and 
the inability to understand or speak Spanish.
Random sample selection
There were 36 participants. Selection was random, based 
on the clinical history number and the application of the 
SPSS v.15 program.
The exercise programme
The programme was designed for a period of 24 weeks: 16 
weeks under the direct or indirect supervision of a physical 
education professional and 8 weeks of autonomous work by 
the patient. There were two 90-minute sessions per week 
which included 1 or 2 series of 8-12 repetitions of 10 correla-
tive exercises for working the muscles of the quadriceps, 
pectorals, ischiotibials, deltoids, abdominals (antihyperten-
sive), biceps, triceps, 2 dorsals and the pelvic floor. It also 
included pelvic floor awareness and control exercises and 
posterior strengthening of the weakened areas, based on 
exercises originating in, and making use of, the overflow 
energy of the healthy muscles. Intensity was between 50% to 
70% of 8 RM, as previously calculated using the Lander test20. 
There was an incremental progression of repetitions, series 
and weight. Once the subject reached 12 repetitions of the 
second series, weight was increased, as long as the weekly 
weight increase was no more than 10% of 8RM. There was a 
strict limit of 70% of 8 RM to avoid the risk of testosterone 
secretion. Individual perception of the intensity of controlled 
exertion was based on a modified Borg CR-1021 subjective 
exertion scale. The programme was therefore flexible and 
adapted to each subject in consideration of their functional 
capacity, stage of illness and symptomatology.
Initial and final evaluation
Evaluation of direct variables
The pre-test evaluation included: anamnesis, a socio-
demographic questionnaire; an anthropometric study; the 
measurement of arterial tension; a questionnaire on 
treatment toxicity; visual analog scales of pain and urinary 
incontinence; a questionnaire on previous exercise habits 
based on the Godin test22; a sub-maximal step-test 
corresponding to the modified Canadian Aerobic Fitness 
Test (mCAFT)23, controlling the frequency, arterial tension 
and the subjective perception of exertion with the Borg CR-
10 scale. 1RM (Lander) was calculated by means of an 
estimation based on the Strength-endurance test of the 
trunk and lower limbs, in accordance with the ASEP 
protocol24. Questionnaires on QoL and Fatigue were also 
completed by the subjects.
The registration of anthropometric variables followed 
the protocol25 and consisted of: weight; body mass index; 
waist-hip ratio; waist measurement; the sum of the seven 
skinfold measurements (pectoral, midaxillary, triceps, 
subscapular, abdominal, suprailium and thigh) and the 
percentage of fat mass, estimated by means of the Jackson 
and Pollock formula26. A biochemical analysis evaluated 
levels of free testosterone, blood lipids (total cholesterol, 
high and low density lipoproteins in cholesterol and 
triglycerides) and SAP levels.
QoL was measured wit the FACT-P, Functional Assessment 
Cancer Therapy Scale-Prostate [Range: 0-156] (4th 
version).
Fatigue was measured by means of the FACIT fatigue 
scale (4th version) [Range: 0-52].
Intensity of incontinence was evaluated by using a visual 
analog categorical scale of four categories from “0: not 
wet” to “10: completely soaked”.
Pain intensity was measured with a visual analog 
numerical scale: “0: no pain” to “10: unbearable pain”.
Strength-endurance was estimated from the total number 
of muscular contractions completed in a cycle of 22 
repetitions/minute marked by a metronome (a Korg MA-30 
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model) programmed to 44 beats/minute and with a light 
weight.
Sub-maximal muscular exertion was considered as the 
maximum weight that the subject could lift for 8 repetitions 
whilst maintaining the correct posture. The weight used 
was 70% of the 8RM calculated from the results of the 
strength-endurance test, based on the Lander formula. The 
test involved two groups of muscles: those of the trunk, 
concentrating on the pectorals, using a horizontal bench; 
and the lower limbs, concentrating on the thighs, using a 
leg press. Maximum muscular strength was indirectly 
(hypothetically) calculated from the 8RM with the Lander 
formula27. This value allowed the calibration of individual 
exercise intensity in accordance with the programmed 
percentages.
Visceral abdominal fatty tissue was measured with a CT-
scanner.
In week 24 the same variables were evaluated, with the 
exception of the anamnesis and the socio-demographic 
questionnaire.
Evaluation of co-variables
The following section explains the evaluation of the co-
variables, including the integrated adherence model, 
symptoms relative to illness and the molecular observation 
unit.
The anamnesis identified the secondary symptoms 
relative to illness and treatment. These were triangulated 
with the symptoms registered in the clinical histories.
The design of the strength programme allowed a flexible 
adaptation to the symptom of urinary incontinence. The 
programme developed active retention strength and 
coordination of the striated muscles of the deep boundaries 
of the pelvic floor; this compensated for the malfunctioning 
of the damaged sphincters and resulted in greater continence 
control.
The adherence model was based on current models using 
variables identified in studies that were related to the 
taking of regular physical exercise. The model used included 
a didactic strategy, introduced in stages, which progressively 
increased autonomy, transferring control of the activity 
from the supervisor to the subject. The objective was that 
the subject would continue the programme at the end of 
the experimental phase. Support given during the programme 
ensured a focus on the most weakened variables. Perception 
of control and self-sufficiency were emphasised. Results 
were evaluated by means of the questionnaire devised by 
Godin22.
The molecular observation unit evaluated the technical 
factors associated with strength-endurance activities. 
Observation guaranteed the health of the subject by 
reducing the risk of injury. The following factors were 
evaluated using the Likert scale: corporal posture at rest 
and in contraction; the biomechanics of contraction, 
including respiratory association; the correct completion of 
the programme; the transference of working load and the 
quality of the basic motor patterns in the process of 
ascending and descending in the step exercise [range: 0-
30]. The comments of the observer were also considered. A 
weekly observation took place which was videoed. An 
average was calculated for the first phase of the programme 
(weeks 1-6) and the autonomous stage (weeks 18-24).
Calculation of sample size and statistical analysis
The sample size calculated for the detection of a difference 
between groups of 5.0 points was the result of the FACT-P 
test (standard deviation [SD] = 9). The test was applied to 
two lines with an alpha risk of 5% and a beta risk of .05. 
The number of subjects required was 33. For paired data 
in the continuous variables that followed a normal 
distribution, the t Student-Fisher test was used with a 
number of degrees of liberty (n-1). For the continuous 
variables that did not follow a normal distribution the 
Wilcoxon or Man Whitney U non-parametric test for paired 
data was employed. The χ2 test was used for the analysis 
of categorical variables. A multivariate model was designed 
with dimensions that integrated the QoL questionnaire. 
The significant variables of the multivariate model were 
studied and they explain the variation of the QoL test 
based on a multiple lineal regression model. The SPSS 
version 15 programme was used for the statistical analyses. 
Significance level was set at 5%.
Of the 46 subjects referred by the Urology service of 
Figueres Hospital, a sample of 36 subjects was selected 
for the study. Attendance at the sessions was over 93% (30 
of 32 sessions). In the course of the study, 3 subjects left 
the programme due to cognitive problems, metastatic 
osseous pain and cardiac insufficiency. The CONSORT flow 
diagram illustrates the study sample procedure (Figure 1). 
At the end of the study (week 24) it was found that 100% 
of the sample had adhered to the activities, having been 
influenced by the variables: perception of control; self-
sufficiency; identification with the therapy; control of 
incontinence and pain; and satisfaction (Figure 1 and 
Table 1).
Results
The results are presented as follows: Sections 1-7 deal with 
the results of the direct variables —anthropometric, 
cardiovascular efficiency at rest, cardiovascular efficiency 
at sub-maximal exertion, arterial pressure, muscle strength, 
QoL (FACT-P), urinary incontinence, fatigue and pain; 
Section 8 describes urinary incontinence and QoL; Section 9 
considers the multivariate model of the dimensions that 
make up the QoL questionnaire; the results of the co-
variants relative to adherence to the programme are given 
in Section 10 and results of the molecular observation unit 
are shown in Section 11.
1. Anthropometric variables
The anthropometric variables showed that at the start of 
the programme the subjects carried a concentration of 
abdominal fat. By the end of the programme there was a 
significant reduction of all measurements and typical 
deviations (Td) of the variables, with the exception of 
weight (Table 2).
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There was a significant reduction in each of the seven 
skinfold measurements; the two that saw the greatest 
reduction were in the abdominal area —the suprailium 
registered an average difference of 6.22 and the abdominal 
skinfold registered an average difference of 5.91. The skinfold 
that registered the least difference was the pectoral (4.75).
2. Cardiovascular variables at rest
There was a significant fall in cardiovascular variables at 
rest. Table 3 details the changes registered for heart rate, 
systolic arterial pressure and diastolic arterial pressure at 
rest.
3. Cardiovascular efficiency variables at sub-
maximal exertion
There was a significant lowering of the cardiovascular 
variables at sub-maximal exertion. The subjective perception 
of effort also registered a significant reduction, as did 
systolic arterial tension, while diastolic arterial tension fell, 
though not significantly (Table 4).
4. Categorisation of arterial pressure variables in 
accordance with the JNC-6
In accordance with the Joint National Committee (JNC)28 
evaluation, there was a 50% fall in arterial hypertension 
(Table 5).
5. Description of muscular strength
The percentage increase in both endurance and 8RM was 
greater in the lower limbs than in the upper body. In the 
pectoral group, strength-endurance increased by 57.83% 
and 8RM by 22.76%. In the lower limbs musculature, 
strength-endurance increased by 61.45% and 8RM by 45.49% 
(Table 6).
24 program weeks
completed
Exercise program start
N = 33
Signed informed consent
N = 36
Cardiac arrythmia (2)
Neurological disorder (1)
Criteria
3 excluded Distance (2)
Transport (1)
Not interested (3)
Inability (2)
Justification
Not agree to participate
N = 47
Referrals
N = 47
Urology Service of Figueres Hospital
Agree to participate
Randomization SPSS V.15
N = 39
Phone contact
N = 8
Preinterventional
medical review
Cognitive problems (1)
Metastatic bone pain (1)
Heart failure (1)
Justification
Abandonment
N = 8
Figura 1  CONSORT flowchart.
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Table 1 Clinical and epidemiological characteristics of the participants
Variable Intervention group (n=33)
Age (years) x– (DS) [range] 71.78 (7.22) [55-83]
Weight (Kg) x– (DS) [range] 80.40 (11.60) [64.2-111.5]
BMI (Kg/m2) x– (DS) [range] 28.67 (2.99) [24.16-33.97]
Arterial tension (mm Hg)
SAP x– (DS)
DAP x– (DS)
150.25 (21.31)
81.90 (11.03)
Heart rate at rest (beats/minute)  x– (DS) 74 (10.74)
TNM Tumour classification, n (%)
Stage I
Stage II
Stage III
Stage IV
Unknown
0 (0)
13 (39.39)
18 (54.54)
1 (3.03)
1 (3.03)
SPA diagnosis (ng/mL)  x– (DS) [range] 17.95 (24.32) [2.84 a >100]
SPA at start of programme (ng/mL)  x– (DS) [range] 0.55 (1.36) [0.01-5.5]
Treatment, n (%)
Surgical (P)
Hormonal (ADT)
Combined 
R + ADT
P + ADT
15 (45.45)
15 (45.45) 
 
1 (3.03) 
2 (6.06)
 
Socio-demographic questionnaire
Civil status
Married
Widowers
Single
30 (90.90) 
2 (6.06) 
1 (3.03)
Occupation
Retired
Active 
31 (93.93)  
2 (6.06)
Previous aerobic exercise, n (%)
Cat 1 ≥ 3 times per week
Intense
Moderate
Light 
Cat 2 < 2 times per week 
Intense 
Moderate 
Light 
24 participants (72.72%) 
1 participant (3.03%) 
11 participants (33.33%) 
12 participants (36.36%) 
9 participants (27.27) 
 
5 participants (15.15%) 
4 participants (12.12%)
Previous strength-endurance exercise, n (%) 
≥ 3 times per week 
< 2 times per week
0 (0) 
0 (0) 
0 (0)
BMI: body mass index; SAP: systolic arterial pressure; DAP: diastolic arterial pressure; SPA: specific prostate antigen; P: 
prostatectomy; ADT: androgenic deprivation therapy; R+ADT: radiotherapy combined with androgenic deprivation therapy; P+ADT: 
prostatectomy combined with androgenic deprivation therapy
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6. Quality of life
The average FACT-P variable showed a significant increase 
by the end of the programme (Table 7).
7. Urinary incontinence, fatigue and pain
There was a significant reduction in incontinence and pain. 
The fall in levels of fatigue was not significant (Table 8).
8. Categorisation urinary incontinence and the 
difference in the FACT-P QoL questionnaire
The variable of the categorical analog visual scale was 
categorised in two groups: Group 1 showed less improvement 
in urinary incontinence and Group 2 showed more 
improvement. The urinary incontinence variable was 
compared with the QoL (FACT-P) questionnaire before and 
after the programme. The average, according to the FACT-P 
Table 2 Anthropometric variables
Description of parameter Pre-test Post-test Pre-test/post-testa
Variables n x– Td x– Td x– Td p*
Weight (Kg) 33 80.40 11.60  79.92 12.08 .478 1.89 .157
BMI (Kg/m2) 33 28.67 2.99  28.20 3.06 .46 1.02 .007*
WHR 33 1.01 0.05   0.99 0.05 .02 .03 .003*
WM 33 104.46 8.68 101.90 8.97 2.56 2.49 ≤ .001*
∑7 skinfolds (mm) 33 219.76 44.17 180.30 37.10 39.46 31.09 ≤ .001*
FM-7 (%) 33 40.87 15.18  28.96 11.42 11.90 10.59 ≤ .001
a Changes observed in the 24 weeks of the intervention programme.
BMI: body mass index; WHR: waist-hip ratio; WM: waist measurement; ∑7 skinfolds: sum of the seven body skinfolds; FM-7 (%): fat 
mass, expressed as a percentage; Td: typical deviation; x–: mean. 
p*: significance value p<.05.
Table 3 Cardiovascular variables at rest
Description of parameter Pre-test Post-test Pre-test/post-testa
Variables n x– Td x– Td x– Td p*
HR-R 33 74.00 10.74 71.96 11.59 2.03 8.79 .02*
SAP-R 33 150.25 21.31 139.96 18.65 10.28 16.16 .001*
DAP-R 33 81.90 11.03 78.65 10.28 3.25 11.61 .062
a Changes observed in the 24 weeks of the intervention programme.
HR-R: heart rate at rest (beats/min); SAP-R: systolic arterial pressure at rest (mmHg); DAP-R: diastolic arterial pressure at rest 
(mmHg); Td: typical deviation; x–: mean. 
p*: significance value p<.05.
Table 4 Cardiovascular parameters in the sub-maximal strength test
Description of parameter Pre-test Post-test Pre-test/post-testa
Variables n x– Td x– Td x– Td p*
HRsub-max 24 122.83 16.98 115.58 19.51 7.25 19.42 .040*
SAPsub-max 24 180.58 22.29 172.79 25.81 7.79 20.66 .039*
DAPsub-max 24 90.16 14.96 83 9.95 7.16 16.88 .029*
Borgsub-max 24 5.08 1.742 4.375 1.61 0.70 1.6 .02
VO2max 30 16.16 8.04 22.26 5.73 6.10 5.07 < .001
a Changes observed in the 24 weeks of the intervention programme.
p*: significance value p<.05.
HRsub-max: sub-maximal heart rate (beats/min); SAPsub-max: sub-maximal systolic arterial pressure (mmHg); DAPsub-max: sub-maximal 
diastolic arterial pressure (mmHg); Borgsub-max: Borg sub-maximal scale of subjective perception of exertion; VO2 max: maximum 
oxygen consumption [ml kg—1 min—1]; Td: typical deviation; x–: mean.
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questionnaire, in Group 2 (more improvement) was higher 
(x– =14.75) than the average for Group 1 (x– = 2.95) (t of 
student = 2.15; p = .039) (Table 9).
9. Multivariate model of the dimensions of the 
FACT-P QoL questionnaire
The multiple lineal regression model (Table 10) analysed 
differences in post and pre-intervention values, for the QoL 
test and each of the dimensions. In addition, it considered 
the coefficient beta for each independent variable —if the 
sign was positive, the value of the variable had increased; 
if the sign was negative, the value of the variable had 
decreased. The variables of the multivariate model that 
were significant and explain the variation in the QoL test 
scores were: the general physical state of health; emotional 
condition and symptoms relative to prostate cancer. Non-
significant variables were family and social environment 
and the fatigue scale. R2 = .933%.
Table 5 Arterial pressure variables
Categories Arterial pressure Pre-test (n=33) Post-test (n=33)
SAP/DAP (mmHg) n % n %
1 Optimal <120 / and <80  5 15.15 5 15.15
2 Normal 120-130 / and 80-85  2 6.06 7 21.21
3 Normal-high 130-139 / and/or 85-89  2 6.06 9 27.27
AHT
4 Stage 1 140-159 / and/or 90-99  5 15.15 3 9.09
5 Stage 2 160-179 / and/or 100-109  2 6.06 0 0
6 Stage 3 ≥180 / and/or ≥110  0 0 0 0
7 ISH ≥140 /<90 17 51.51 9 27.27
All variables are values at rest. If SAP or DAP are in different categories, the recommended interval is the lowest indicated.
SAP: systolic arterial pressure; DAP: diastolic arterial pressure; ISH: isolated systolic hypertension; AHT: arterial hypertension; 
mmHg: millimetres of mercury.
Table 6 Changes in means and typical deviation (Td) of muscular strength
Description of parameter Pre-test Post-test Pre-test-Post-testa
Variables Grup Rang n x– Td x– Td x– Td p*
Pre-test Post-test
Mend Pec [2-23] [7-42] 31 12.83 5.20 20.25 7.87 7.41 6.97 <.001*
LL [8-50] [10-90] 32 19.43 9.49 31.37 18.12 11.93 18.87 <.001*
8RM Pec [5.3-36.5] [6.6-45.6] 32 21.66 8.38 26.59 8.91 4.93 4.37 <.001*
LL [6.6-135.4] [10.7-159.6] 32 57.59 35.19 83.79 43.33 26.19 24.78 <.001*
aChanges observed in the 24 weeks of the intervention programme.
p*: significance value p<.05.
Mend: muscular endurance; 8RM: sub-maximal exertion, calculated using Lander formulas1,20; Pec: pectoral; LL: lower limbs;  
 Td: typical deviation; x–: mean.
There was higher significance in muscular-strength endurance and sub-maximal exertion. The effect was greater in the lower limbs 
(Table 7). Lander Formula (1985): Weight raised (Kg) / [1.013 — 0.0267123 NR].
Table 7 Changes in means and typical deviation (Td) of FACT-P
Description of parameter Pre-test Post-test Related differencesa
Questionnarie Range n x– Td x– Td x– Td p*
FACT-P [0-156] 33 107.11 19.91 116.5 17.14 9.39 16.55 0.003*
aChanges observed in the 24 weeks of the intervention programme.
p*: significance value p<.05.
FACT-P: QoL questionnaire on prostate cancer; Td: typical deviation; x–: mean.
Multivariate model of the dimensions that make up the dimensions of the FACT-P QoL questionnaire.
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New coefficients were obtained from the significant 
variables (Table 11).
10. Integrated adherence model
Adherence to the exercise programme was 100%. The results 
showed that the subjects autonomously continued with the 
exercise programme due to the perception of improvement 
in the symptoms of incontinence and pain and a general 
post-exercise session feeling of wellbeing. Perception of 
control, self-sufficiency and willpower variables were 
decisive in continuance in the long-term. Two variables not 
included in the model that should be mentioned are 
knowledge of the therapeutic dose and psychosocial 
distraction during the activity.
11. Molecular observation unit
The group average in the first phase, weeks 1-6, was 12.5 
points. The average for the final, autonomous phase, weeks 
18-24, was 24 points. The observations in the final phase 
highlighted the improvement in the quality of basic motor 
patterns, especially in coordination when ascending and 
descending in the mCAFT sub-maximal aerobic step test.
Discussion
The results show that strength-endurance exercise signifi-
cantly improves the QoL of prostate cancer patients. The 
QoL questionnaire revealed improvements in the physical 
dimension (including reduction of pain), the functional 
dimension (including improved continence) and the 
emotional dimension.
There was clear and evident progress in the sub-maximal 
and strength-endurance variables. As in the work of 
Latham17, it was noted that an increase in strength had a 
positive retroaction effect on the capacity, technical 
execution and quality of the basic motor patterns when 
walking and ascending-descending the step. This result was 
confirmed by both the changes identified in the periodic 
Table 8 Changes in means and typical deviation of urinary incontinence, fatigue and pain
Description of parameter Pre-test Post-test Related differencesa
Questionnarie Rang n x– Td x– Td x– Td p*
VAS-UI [0-10] 33 3.79 2.54 1.03 0.918 2.75 1.88 .000*
FACIT [0-52] 33 39.91 9.72 42.90 6.60 2.99 10.46 .110
VAS-P [0-10] 33 4.57 2.41 2.66 1.79 1.90 1.25 ≤ .001
aChanges observed in the 24 weeks of the intervention programme.
p*: significance value p <.05.
VAS-UI: visual analogue scale of urinary incontinence; FACIT: fatigue questionnaire; VAS-P: visual analogue scale of pain; x–: mean; 
Td: typical deviation.
Table 9 Urinary incontinence
Description of parameter Related differences T test for equality of means
Questionnaire VAS-C n x– Td t p*
FACT-P DIF 1 (n=15)  2.95 14.58 —2.152 0.039
2 (n=18) 14.75 16.50
FACT-P DIF: the difference in the result of the QoL questionnaire between the final value on finalising the intervention and the 
initiation of the intervention. VAS-C: visual analogue scale of continence; Td: typical deviation; x–: mean. 1: less improvement in 
urinary incontinence; 2: more improvement in urinary incontinence.
Table 10 FACT multiple regression
FACT Questionnaire dimensions T Beta p*
1. PWB: Physical wellbeing 2.528 .249 .018
2. SWB: Social and family wellbeing 1.170 .122 .252
3. EWB: Emotional wellbeing 3.769 .404 .001
4. PCS: Other concerns 3.909 .365 .001
5. FACIT: Fatigue scale —3.19 —.028 .752
R2 = .933%
p*: significance value p <.05.
Table 11 FACT coefficients
FACT-P Questionnaire dimensions T Beta p*
1. PWB: Physical wellbeing 3.32 .285 .002
3. EWB: Emotional wellbeing 4.54 .418 .000
4. PCS: Symptoms 4.56 .404 .000
p*: significance value p <.05.
PCS: in the QoL questionnaire, PCS refers to “other 
concerns”, attributed to symptoms relative to illness and 
treatment.
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checks of the molecular observation unit and the mCAFT 
sub-maximal aerobic step test.
The improvement in strength-endurance was superior to 
sub-maximal strength. In both cases, the improvement was 
greater in the lower limbs than the trunk. This result should 
be seen in the context of the fact that in older people, the 
natural physiological loss of strength usually occurs earlier 
in the lower limbs than in the upper body. Moreover, the 
increase in extensor strength in the lower limbs correlates 
with the increase in walking speed, self-perception and the 
restoration of balance29. This reduces the risk of fall and 
fracture and contributes to a general improvement of 
QoL30.
The increase in strength correlates with the halting of 
the catabolic process in the muscular system and an 
improvement in the condition of sarcopenia that is 
aggravated by cancer. The recuperation of the muscular 
mass and the intensity and quality of the muscular 
contraction generates an efficient movement arc. These 
factors signal a general improvement in functionality 
and the ability and movement demanded by daily life 
activities, retarding the manifestation of fatigue and 
resulting in an improved self-perception of health by older 
people31-33.
Age and hormone treatment are factors that provoke an 
accelerated loss of osseous mineral density34. A strength-
endurance programme is an ideal therapy to retard the 
process of osteoporosis and reduce the risk of fractures, as 
exercise increases bone density, porosity and solidity35. 
Research has revealed a direct, proportional relationship 
between muscular-endurance exercise and osseous mineral 
density. This effect has also been identified in older people, 
although the degree of change depends on the initial 
condition of the bone structure32.
Against this, it should be recognised that muscular-
endurance exercise involves a greater risk of injury to soft 
tissue parts, mainly the tendinous intersections36. This risk 
is higher in people suffering illnesses and this underlines 
the importance of determining the most efficient exercise 
programme for obtaining the greatest benefits for the 
osseous and muscular structure and minimising the risk of 
injury.
The review of previous studies showed that the minimum 
duration of an exercise programme aimed at increasing 
osseous mineral density is 24 weeks37. The programme used 
in this study was 24 weeks and this overcomes one of the 
methodological limitations that have been identified in other 
similar studies10. The results obtained justify the effect of 
strength-exercise on osseous health, though the importance 
of the promotion of good nutritional habits, especially the 
ingestion of calcium, should not be forgotten38.
The degeneration of muscular-skeletal capacity and, 
especially, the lower limbs is a cause of the fall-fracture-
dependence triad of the older person. This risk increases 
enormously when the individual is in a fragile physical 
condition29,39. The impact of a fall on osteoporotic bone 
often results in fracture, with the consequent loss of 
mobility and the possible generation of post-fall syndrome 
due to functional dependence40. The initial effect or the 
exercise programme was improved muscular conditioning 
and this led to better osseous health. Osteomuscular 
improvement allows the older person to maintain autonomy 
and this reduces the risk of dependence that is often caused 
by cancer and the treatment of the disease41-43.
Cardiovascular, metabolic and anthropometric decom-
pensation is common in prostate cancer patients. The effect 
is provoked by the deficit in the secretion of testosterone. 
The pre-test phenotype of the participants in this study was 
Type II (android). The excess fat in the abdominal area was 
identified by waist girth, waist-hip ratio and the two biggest 
skinfolds —suprailium and abdominal. The inter-abdominal 
fat deposit directly correlated with the cardiovascular risk 
factors. If these indicators are not reverted they become 
morbimortality risk factors44.
ACSM12 aerobic type exercise is recommended for reducing 
obesity. The results of this study show that strength-
endurance exercise is effective for improving tissue quality. 
The results showed a significant reduction in the 
anthropometric variables: BMI, waist girth, the sum of the 
seven skinfolds and the percentage of body fat. This result 
correlates with the cardiovascular improvements identified 
through the diminution of the variables: heart rate, arterial 
tension and the subjective perception of exertion (at rest 
and sub-maximal) although the exact significance of the 
relationship was not clearly defined. The post-test showed 
a greater capacity to exercise at a higher intensity and a 
more efficient post-exercise cardiovascular recovery. There 
was a gradual fall in arterial tension that was evident and 
significant from the sixth week of the programme. At the 
end of the first experimental phase the subgroup of subjects 
with hypertension was reduced by 50% due to the fall in 
systolic arterial pressure. Results further confirm that the 
programme had a significant antihypertensive effect on the 
systolic arterial pressure of the subgroup of subjects with 
hypertension45 although it cannot be confirmed that the 
effect is long-term. The cardiovascular improvement 
corroborates the principle of the interrelationship between 
capacities: the improvements in strength-endurance and 
sub-maximal strength generated an adaptation in aerobic 
capacity registered in the variables of cardiovascular 
efficiency at rest and in the mCAFT sub-maximal fitness 
test. This was evidenced in a reduction of cardiovascular 
stress with more exercise and a lower subjective perception 
of the exertion required. More research is necessary in 
order to quantify the relationship between an exact degree 
of strength exercise and its effect on cardiovascular 
health.
The improvements in the anthropometric profile and 
cardiovascular response, as described above, are 
determinants in the overall progress of factors that are 
interrelated with the metabolic system. This effect was 
identified through the joint analysis derived from the 
reduction of the variables concerning lipids in the blood, 
arterial tension at rest and during activity, the reduction 
in abdominal obesity and improved glycaemia that 
indicated greater sensibility to insulin46. These results are 
in line with those of Warburton and confirm that 
improvements in the metabolic syndrome correlate with 
improvements in the functional dimension and the QoL of 
the older person32.
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The programme managed to reduce, control and revert 
symptoms of incontinence, fatigue and pain. This effect was 
achieved by the capacity of the programme to adapt to the 
most common symptoms associated with the illness and its 
treatment. For example, in relation to incontinence, the 
strength programme included the management of three 
consecutive phases: the sensory perception of the pelvic 
floor; strengthening; and irradiated overflow exercises from 
the healthy musculature to the atrophied and damaged 
muscles of the pelvic floor. This model, organised in phases 
and adapted to the symptom of incontinence, achieved a 
significant improvement in the QoL of the subgroup affected 
by urinary incontinence, as compared with the non-affected 
sub-group or the results of similar programmes that were 
not able to be adapted to symptoms47. The specific 
mechanisms that mediate the improvement are consciousness 
and continence control. This result may have had a further, 
positive impact on other dimensions of the QoL questionnaire, 
for example, recovery of social network.
The American Society of Clinical Oncology (2008), confirm 
that QoL is a strong and independent indicator in cancer 
survival. In this study, the dimensions of the QoL 
questionnaire that saw a significant improvement were 
personal functional capacity, emotional wellbeing and the 
dimension that included symptoms relative to the illness 
(incontinence, pain and fatigue). From the first phase of 
the programme, a contextualised study for the multi-
disciplinary promotion of the variables that correlate with 
adherence was undertaken; the basis of the study being 
older men suffering from prostate cancer and their socio-
familial environment. This construct did not consider 
adherence exclusively as a final value of the study but as 
contingent support offered in the experimental stage, in 
relation to the weakest variables concerning perception of 
control, self-sufficiency and perception of improvement. It 
is clear that this encouraged the autonomous continuance 
of the programme once the experimental phase was 
complete —the adherence level was 100%. It is worth noting 
that other (new) significant variables that should be 
integrated into the model are knowledge of the therapeutic 
dose and psychosocial distraction.
A global consideration of the results leads us to the 
controversy and debate concerning the effectiveness of 
population screening and diagnosis of prostate cancer based 
on the SAP test. This also raises the question of the need for 
low-risk prostate cancer treatment; a question that is 
justified by the chain of joint or sequential risk factors that 
determine the metabolic syndrome of the older male being 
treated for prostate cancer. In this study, we have identified: 
overweight, arterial hypertension (with isolated systolic 
hypertension), high heart rate at rest, high cholesterol, an 
increased level of high density lipoproteins, excessive 
saturated fats in the diet and a sedentary lifestyle. The 
combination of these factors significantly increases the risk 
of cardiovascular illness48. If, to this profile, we add the 
secondary effects of the illness and its treatment, such as 
urinary incontinence, sexual dysfunction or impotence, 
fatigue, distress, social isolation etc., it can be seen that 
the impact of prostate cancer treatment on the QoL of the 
sufferer is greater than the impact of the illness itself. We 
conclude this section with a reference to Traish, who 
commented that the identification of these factors exposes 
the dark, silent and unknown face of androgen deprivation 
treatment49.
 Conclusions
•  The strength-endurance programme is a natural, non-in-
vasive intervention that is economical and effective and 
can complement socio-health attention and treatment.
•  Long term metabolic decompensation supposes a high risk 
of cardiovascular pathologies. These risks are aggravated 
by cancer treatment, both in terms of expectancy and 
QoL. Given this situation, proactive health initiatives are 
justified as they may ameliorate secondary effects and 
the risks generated by cancer treatment as well as leading 
to improvements in physical and functional capacity and 
the general health of the patient.
•  The strength programme led to improved strength-
endurance and sub-maximal strength capacity. The 
general improvement in strength was greater in the lower 
limbs than in the trunk. There was a transfer of strength 
to aerobic capacity and to basic motor pattern skills. 
Functional progress had a positive effect on all other QoL 
dimensions.
•  The programme reduced cardiovascular risk through the 
diminution of the anthropometric variables, above all, 
the percentage of fatty tissue (especially in the abdominal 
area) and the level of arterial tension.
•  The programme had an antihypertensive effect that was 
most evident in the subjects that suffered hypertension. 
There was a significant effect on systolic arterial pressure 
from the sixth week of the programme.
•  The results justify the flexibility and capacity of the 
programme to adapt to the symptoms of urinary 
incontinence, fatigue and pain. The reduction in the 
intensity of these symptoms led to improvements in the 
psychological and social wellbeing of the subjects.
•  There was a significant improvement in the cardiovascular 
variables at rest and at sub-maximal exertion and in the 
subjective perception of strength.
•  The results confirm that the programme is valid, 
sustainable and the best intervention aimed at the older 
male suffering from prostate cancer. This type of 
programme allows direct control of the vital signs of life 
and reduces the risk of dyspnoea and falling. Furthermore 
it allows for immediate treatment in the case of 
emergency.
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